Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China
信迪利单抗与帕博利珠单抗治疗晚期或复发性儿童恶性肿瘤的安全性和有效性:一项中国真实世界研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1608844
Mao, Lei; Li, Mengzhen; Wu, Linnan; Wang, Juan; Que, Yi; Sun, Feifei; Huang, Junting; Lu, Suying; Zhen, Zijun; Zhu, Jia; Song, Mengjia; Zhang, Yizhuo